Business Segments · Goodwill

Proprietary Products — Goodwill

West Pharmaceutical Services Proprietary Products — Goodwill increased by 4.2% to $80.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.2%, from $76.80M to $80.00M.

Analysis

StatementSegment
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ4 2025
Rolls up toGoodwill

How to read this metric

A stable or growing balance indicates successful past acquisitions, while a sudden decrease suggests impairment charges due to underperforming acquired assets.

Detailed definition

This represents the intangible asset value recorded when the company acquires other businesses within the proprietary pr...

Peer comparison

Comparable to goodwill balances in any company that utilizes an M&A-based growth strategy.

Metric ID: wst_segment_proprietary_products_goodwill

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$80.10M$77.90M$78.90M$76.80M$80.00M
QoQ Change-2.7%+1.3%-2.7%+4.2%
YoY Change-2.7%+1.3%-2.7%+4.2%
Range$76.80M$80.10M
CAGR-0.1%
Avg YoY Growth+0.0%
Median YoY Growth-0.7%

Frequently Asked Questions

What is West Pharmaceutical Services's proprietary products — goodwill?
West Pharmaceutical Services (WST) reported proprietary products — goodwill of $80.00M in Q4 2025.
How has West Pharmaceutical Services's proprietary products — goodwill changed year-over-year?
West Pharmaceutical Services's proprietary products — goodwill increased by 4.2% year-over-year, from $76.80M to $80.00M.
What does proprietary products — goodwill mean?
The value of intangible assets like brand and customer base acquired through past business purchases.